سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

The Effect of miR-34a and miR-34b Polymorphisms on Clinical-Pathological Characteristics of Renal Cell Carcinoma

Publish Year: 1401
Type: Journal paper
Language: English
View: 249
این Paper فقط به صورت چکیده توسط دبیرخانه ارسال شده است و فایل کامل قابل دریافت نیست. برای یافتن Papers دارای فایل کامل، از بخش [جستجوی مقالات فارسی] اقدام فرمایید.

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

Export:

Link to this Paper:

Document National Code:

JR_TUMS-4-4_007

Index date: 10 January 2023

The Effect of miR-34a and miR-34b Polymorphisms on Clinical-Pathological Characteristics of Renal Cell Carcinoma abstract

Introduction: MicroRNAs can regulate expression of gene by binding to 3'-UTRs (untranslated region) of mRNAs. Genetic changes in miRNA binding domains affect susceptibility to various diseases, including cancer. This research presented to determine the impact of pri-miR-34b T> C rs4938723 and miR34a A>C rs6577555 polymorphism in renal cell carcinoma.  Method: This case-control study has been done on 100 patients with RCC and 100 healthy matched control in two referral urology centers in Tehran, Iran. The miRNA-34a/b polymorphisms mentioned in the genomes of healthy individuals and patients with RCC were studied by the tetra arms PCR method. Then statistical studies were performed by SPSS software, using the independent sample T-test and Chi-square. A P-value lower than 0.05 is significant.Results: The connection between pri-miR-34b T>C and miR34a A>C variants were considered according to age, sex, tumor site, metastasis site, tumor stage, and tumor grade in this study. No statistically significant difference existed between the two study groups regarding gender and age. Smoking and alcohol consumption were significantly higher in RCC patients, so we suggest them as the main risk factors. The rs6577555 polymorphism showed a significant association with the classification of tumor type (P-value=0.047), but rs4938723 SNP did not correlate with the tumor type.    Conclusions: The findings indicated that rs4938723 and rs6577555 polymorphism might be a risk for predisposition to RCC in the population of Iran. More research with greater sample sizes and various ethnicities must approve our findings.

The Effect of miR-34a and miR-34b Polymorphisms on Clinical-Pathological Characteristics of Renal Cell Carcinoma Keywords:

The Effect of miR-34a and miR-34b Polymorphisms on Clinical-Pathological Characteristics of Renal Cell Carcinoma authors

Mohammad Soleimani

Department of urology, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences; Tehran, Iran

Behzad Narouie

Department of Urology, Zahedan University of Medical Sciences, Zahedan, Iran

Abdolsamad Sheikhzadeh

Urology and Nephrology Research Center, Department of Urology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Reza Mohammadi Farsani

School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohammad Reza Fattahi

Student Research Committee, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Helia Azodian Ghajar

Department of Medical Genetics, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, ...
van Oostenbrugge TJ, Fütterer JJ, Mulders PFA. Diagnostic Imaging for ...
Maher ER. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and ...
Pimienta AL, Billings TA, Fish RG. Paraneoplastic Phenomena in a ...
Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, ...
Karami S, Boffetta P, Brennan P, Stewart PA, Zaridze D, ...
Meo AD, Wang C, Cheng Y, Diamandis EP, Yousef GM. ...
Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. ...
Aghamir SMK, Nasir Shirazi M, Khatami F. A Systematic Review ...
Aghamir SMK, Heshmat R, Ebrahimi M, Ketabchi SE, Dizaji SP, ...
Spadaccino F, Gigante M, Netti GS, Rocchetti MT, Franzin R, ...
Son MS, Jang MJ, Jeon YJ, Kim WH, Kwon C-I, ...
Peterson S, Thompson J, Ufkin M, Sathyanarayana P, Liaw L, ...
Misso G, Di Martino MT, De Rosa G, Farooqi AA, ...
Zhang S, Qian J, Cao Q, Li P, Wang M, ...
Li H, Diao S, Li J, Ma B, Yuan S. ...
Tao T, Chen S, Xu B, Liu C, Wang Y, ...
Wang X, Lu X, Fang Y, Chen H, Deng X, ...
Sun Y, Peng R, Li A, Zhang L, Liu H, ...
Wei GJ, Yuan MQ, Jiang LH, Lu YL, Liu CH, ...
Hashemi M, Danesh H, Bizhani F, Narouie B, Sotoudeh M, ...
Hashemi M, Hasanpour V, Danesh H, Bizhani F, Narouie B. ...
نمایش کامل مراجع